Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 21/7/2017
SIETES contiene 91904 citas

 
 
 1 a 20 de 323 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Xu J, Emenanjo O, Ortwerth M, Lurie P. Association of appearance of conflicts of interest with voting behavior at FDA advisory committee meetings—A cross-sectional study. JAMA Intern Med 2017;177:1038-40. [Ref.ID 101664]
2. Cita con resumen
3. Cita con resumen
Goldacre B. The WHO joint statement from funders on trials transparency. BMJ 2017;357:j2816. [Ref.ID 101660]
4. Cita con resumen
Armstrong D. Kentucky Senate president urges release of secret OxyContin records. STAT 2017:1. [Ref.ID 101657]
6. Cita con resumen
Spelsberg A , Prugger C , Doshi P , Ostrowski K , Witte T , Hüsgen D , Keil U , for the Working Group on Health and Working Group on Freedom of Information Transparency International Deutschland eV. Contribution of industry funded post-marketing studies to drug safety: survey of notifications submitted to regulatory agencies. BMJ 2017;356:j337. [Ref.ID 101390]
7. Cita con resumen
Anónimo. UK’s NICE recommends ibrutinib after discount. DIA Daily 2016:2. [Ref.ID 100979]
9. Cita con resumen
Anónimo. EMA releases clinical trial data in transparency effort. DIA Daily 2016:1. [Ref.ID 100849]
12.Tiene citas relacionadas Cita con resumen
Davis C, Lexchin J, Jefferson T, Gotzsche P, McKee M. "Adaptive pathways” to drug authorisation: adapting to industry?. BMJ 2016;354:i4437. [Ref.ID 100602]
13.Enlace a cita original Cita con resumen
Anónimo. La falsa transparencia y el lavado de cara de la industria farmacéutica. NoGracias 2016:1 de julio. [Ref.ID 100507]
14. Cita con resumen
Anónimo. NICE endorses bosutinib for treatment of myeloid leukemia. DIA Daily 2016:3. [Ref.ID 100484]
15. Cita con resumen
Anónimo. EU ombudsman: EMA should release adalimumab data. DIA Daily 2016:1. [Ref.ID 100412]
16. Cita con resumen
Garattini S. The European Medicines Agency is still too close to industry. BMJ 2016;353:i2412. [Ref.ID 100360]
17.Tiene citas relacionadas Cita con resumen
Dubicka B, Cole-King A, Reynolds S, Ramchandani P. Paper on suicidality and aggression during antidepressant treatment was flawed and the press release was misleading. BMJ 2016;352:i911. [Ref.ID 100053]
19.Tiene citas relacionadas Cita con resumen
Moncrieff J. Misrepresenting harms in antidepressant trials. BMJ 2016;352:i217. [Ref.ID 100033]
20. Cita con resumen
Gubar S. Living with cancer: a broken covenant with patients. N Y Times (Print) 2016:1. [Ref.ID 99979]
Seleccionar todas
 
 1 a 20 de 323 siguiente >>